Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Equity

v3.19.1
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Series A-1 Preferred Stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Series A Preferred Stock
Additional Paid-In Capital
Series A-1 Preferred Stock
Retained Earnings / (Accumulated Deficit)
Balance, beginning amount at Dec. 31, 2015 $ 6,342     $ 2 $ 23,946     $ (17,606)
Balance, beginning shares (shares) at Dec. 31, 2015       22,640,611        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 872       872      
Issuance of common stock from exercise of stock options (shares)       462,117        
Issuance of common stock from exercise of stock options 111       111      
Accretion of preferred stock   $ (6,789) $ 0     $ (6,789)    
Net Income 350             350
Balance, ending amount at Dec. 31, 2016 886     $ 2 18,140     (17,256)
Balance, ending shares (shares) at Dec. 31, 2016       23,102,728        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense $ 843       843      
Issuance of common stock from exercise of stock options (shares) 464,600     464,600        
Issuance of common stock from exercise of stock options $ 229       229      
Accretion of preferred stock   (292) (4,590)     $ (292) $ (4,590)  
Net Income 22,811             22,811
Issuance of warrants classified as a liability (3,313)       (3,313)      
Sale of Common Stock (shares)       4,140,000        
Sale of Common Stock 11,952     $ 1 11,951      
Balance, ending amount at Dec. 31, 2017 28,526     $ 3 22,968     5,555
Balance, ending shares (shares) at Dec. 31, 2017       27,707,328        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense $ 1,593       1,593      
Issuance of common stock from exercise of stock options (shares) 547,820     547,820        
Issuance of common stock from exercise of stock options $ 357       357      
Accretion of preferred stock   $ 0 $ (925)       $ (925)  
Net Income 20,738             20,738
Warrant liability reclassifications 4,541       4,541      
Shares repurchased (shares)       (686,492)        
Shares repurchase (2,023)             (2,023)
Balance, ending amount at Dec. 31, 2018 $ 54,679     $ 3 $ 28,534     $ 26,142
Balance, ending shares (shares) at Dec. 31, 2018       27,568,656